{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:35:04Z","timestamp":1790742904866,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","award":["CBIR12MIG011"],"award-info":[{"award-number":["CBIR12MIG011"]}],"id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]},{"name":"by Exploration-Hypothesis Development","award":["TS110033"],"award-info":[{"award-number":["TS110033"]}]},{"DOI":"10.13039\/100000090","name":"Department of Defense - CDMRP - TSCRP (G.D.)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neuroscience.2017.04.026","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T21:00:57Z","timestamp":1493326857000},"page":"196-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Differential roles for Akt and mTORC1 in the hypertrophy of Pten mutant neurons, a cellular model of brain overgrowth disorders"],"prefix":"10.1016","volume":"354","author":[{"given":"Ina","family":"Nikolaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana M.","family":"Kazdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"D'Arcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2017.04.026_b0005","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nm.3982","article-title":"An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development","volume":"21","author":"Baek","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0015","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","article-title":"Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function","volume":"31","author":"Bateup","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jmgm.2013.12.002","article-title":"Insight into the structural mechanism for PKBalpha allosteric inhibition by molecular dynamics simulations and free energy calculations","volume":"48","author":"Chen","year":"2014","journal-title":"J Mol Grap Model"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","article-title":"Evolving neurobiology of tuberous sclerosis complex","volume":"125","author":"Crino","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.drudis.2012.04.010","article-title":"Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries","volume":"17","author":"Don","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.semperi.2014.10.006","article-title":"Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations","volume":"39","author":"Hevner","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0040","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0045","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1038\/ncomms11753","article-title":"Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement","volume":"7","author":"Hsieh","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0055","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awv045","article-title":"PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia","volume":"138","author":"Jansen","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000337229","article-title":"Development and Characterization of NEX- Pten, a Novel Forebrain Excitatory Neuron-Specific Knockout Mouse","volume":"34","author":"Kazdoba","year":"2012","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0065","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nn.2408","article-title":"GSK-3 is a master regulator of neural progenitor homeostasis","volume":"12","author":"Kim","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0075","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1073\/pnas.2132711100","article-title":"MTor is required for hypertrophy of Pten-deficient neuronal soma in vivo","volume":"100","author":"Kwon","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0080","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"MTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.2329","article-title":"De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly","volume":"44","author":"Lee","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0090","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1528-1167.2008.01998.x","article-title":"Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience","volume":"50","author":"Lerner","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nm.3824","article-title":"Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy","volume":"21","author":"Lim","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.20949","article-title":"Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia","volume":"60","author":"Ljungberg","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.wco.0000218234.67840.cb","article-title":"Epilepsy surgery in patients with malformations of cortical development","volume":"19","author":"Luders","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0115","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1523\/JNEUROSCI.0061-11.2011","article-title":"Pten knockdown in vivo increases excitatory drive onto dentate granule cells","volume":"31","author":"Luikart","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","article-title":"Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions","volume":"9","author":"Magri","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0125","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamaneurol.2016.0363","article-title":"Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism","volume":"73","author":"Mirzaa","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.celrep.2015.07.013","article-title":"Impaired reelin-Dab1 signaling contributes to neuronal migration deficits of tuberous sclerosis complex","volume":"12","author":"Moon","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/epi.12946","article-title":"MTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia","volume":"56","author":"Nguyen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0145","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.03.010","article-title":"Somatic activation of AKT3 causes hemispheric developmental brain malformations","volume":"74","author":"Poduri","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway","volume":"142","author":"Polivka","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Riviere","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0165","doi-asserted-by":"crossref","first-page":"e12703","DOI":"10.7554\/eLife.12703","article-title":"Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy","volume":"4","author":"Roy","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0170","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1528-1167.2011.03280.x","article-title":"Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice","volume":"52","author":"Sunnen","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0175","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2006.20.1.8","article-title":"Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome","volume":"20","author":"Wang","year":"2006","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0180","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/hmg\/dds156","article-title":"The differential effects of prenatal and\/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex","volume":"21","author":"Way","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2014.00001","article-title":"Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures","volume":"7","author":"Weston","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0190","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of Tuberous Sclerosis Complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0195","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.conb.2012.05.004","article-title":"PTEN signaling in autism spectrum disorders","volume":"22","author":"Zhou","year":"2012","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.04.026_b0200","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217302841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217302841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:43:17Z","timestamp":1759678997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452217302841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":40,"alternative-id":["S0306452217302841"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential roles for Akt and mTORC1 in the hypertrophy of Pten mutant neurons, a cellular model of brain overgrowth disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}